Literature DB >> 17976144

Immunologic principles of allergic disease.

Marco Averbeck1, Carl Gebhardt, Frank Emmrich, Regina Treudler, Jan C Simon.   

Abstract

Allergy either results from a pathological excessive immune reaction, or from the defective induction of tolerance to otherwise harmless antigens. Allergic reactions are mounted by mechanisms of innate and adaptive immunity. The development of an allergic response can be divided in sensitization and elicitation phases. Immediate type allergic reactions (e.g. anaphylaxis, urticaria, rhinoconjunctivitis allergica, allergic asthma) are mediated by IgE antibodies which are produced by B cells stimulated by allergen-specific Th2 cells. Crosslinking of allergen-specific IgE on membrane surfaces of mast cells and basophilic granulocytes leads to release of soluble mediators which may cause systemic symptoms within minutes to hours. The following infiltration of eosinophilic granulocytes and Th2 cells directs chronic inflammation. Humoral cytotoxic immune reactions (e.g. drug induced cytopenia) are mediated by IgG and IgM antibodies which are directed against membrane associated antigens. IgG and IgM antibodies directed against soluble antigens elicit immune complex mediated cytotoxicity (e.g.drug induced vasculitis). Delayed type immune reactions (e.g.contact dermatitis) are based on the activation of antigen specific CD4(+) and CD8(+) T cells and need 24 h to 48 h to develop. Upon recurrent contact with identical antigens, recruitment of CD4(+) and CD8(+) T cells cause inflammation and cytotoxic induced apoptosis in target cells as well as cytokine mediated leukocyte infiltration. Subsequent immigration of CD4(+) Th2 cells provides anti-inflammatory mechanisms leading to resolution of the inflammatory response and tissue repair.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976144     DOI: 10.1111/j.1610-0387.2007.06538.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  14 in total

1.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

2.  Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome.

Authors:  Angela C Sosa; Barbara Kariuki; Qi Gan; Alan P Knutsen; Clifford J Bellone; Miguel A Guzmán; Luis A Barrera; Shunji Tomatsu; Anil K Chauhan; Eric Armbrecht; Adriana M Montaño
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.

Authors:  Ranit Naor; Vered Domankevich; Shaily Shemer; Luba Sominsky; Ella Rosenne; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2008-10-08       Impact factor: 7.217

4.  Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay.

Authors:  Brian Nolen; Matt Winans; Adele Marrangoni; Anna Lokshin
Journal:  J Immunol Methods       Date:  2009-04-05       Impact factor: 2.303

5.  Immunological and genetic aspects of asthma and allergy.

Authors:  Anne-Marie Madore; Catherine Laprise
Journal:  J Asthma Allergy       Date:  2010-08-20

Review 6.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

7.  Early Exposure to Respiratory Allergens by Placental Transfer and Breastfeeding.

Authors:  Patricia Macchiaverni; Leandro H Ynoue; Christina Arslanian; Valérie Verhasselt; Antonio Condino-Neto
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

8.  Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.

Authors:  Yutong Zhao; Jiankun Tong; Donghong He; Srikanth Pendyala; Berdyshev Evgeny; Jerold Chun; Anne I Sperling; Viswanathan Natarajan
Journal:  Respir Res       Date:  2009-11-20

9.  Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma.

Authors:  Khoa D Nguyen; Christopher Vanichsarn; Alison Fohner; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2009-01-18       Impact factor: 10.793

10.  T regulatory cells: an overview and intervention techniques to modulate allergy outcome.

Authors:  Subhadra Nandakumar; Christopher Wt Miller; Uday Kumaraguru
Journal:  Clin Mol Allergy       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.